CHGCF vs MRK: Which Stock is Better?
Side-by-side comparison of Chugai Pharmaceutical Co. Ltd and Merck & Co Inc in 2026
CHGCF
Chugai Pharmaceutical Co. Ltd
$60.19
MRK
Merck & Co Inc
$119.07
Key Metrics Comparison
| Metric | CHGCF | MRK | Winner |
|---|---|---|---|
| Market Cap | $99.06B | $294.39B | MRK |
| P/E Ratio | 36.04 | 16.36 | MRK |
| EPS (TTM) | $1.67 | $7.28 | MRK |
| Revenue Growth | 0.1% | 0.1% | CHGCF |
| Gross Margin | 71.1% | 77.2% | MRK |
Analyze CHGCF
Full quant analysis
Analyze MRK
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHGCF or MRK a better investment?
Comparing CHGCF and MRK: Chugai Pharmaceutical Co. Ltd has a market cap of $99.06B while Merck & Co Inc has $294.39B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHGCF and MRK?
CHGCF (Chugai Pharmaceutical Co. Ltd) and MRK (Merck & Co Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHGCF or MRK?
Based on P/E ratios, MRK trades at a lower multiple (16.4x vs 36.0x).
Which is growing faster: CHGCF or MRK?
CHGCF has higher revenue growth at 0.1% vs 0.1% for MRK.
Which company is more profitable: CHGCF or MRK?
Merck & Co Inc (MRK) has higher gross margins at 77.2% compared to 71.1% for CHGCF.
Which is the larger company: CHGCF or MRK?
Merck & Co Inc (MRK) is larger with a market cap of $294.39B compared to $99.06B for CHGCF.
Should I buy CHGCF or MRK in 2026?
Both CHGCF and MRK have investment merit. CHGCF trades at $60.19 while MRK trades at $119.07. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHGCF and MRK stock?
Key differences: Market Cap ($99.06B vs $294.39B), P/E Ratio (36.0x vs 16.4x), Revenue Growth (0.1% vs 0.1%), Gross Margin (71.1% vs 77.2%).